SPIA
ANGO icon

Steward Partners Investment Advisory’s AngioDynamics ANGO Stock Holding History

Steward Partners Investment Advisory’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,344
Closed -$13.9K – 3320
2023
Q1 		$13.9K Hold
1,344
– – ﹤0.01% 2409
2022
Q4 		$18.5K Sell
1,344
-711
-35% -$9.89K ﹤0.01% 2267
2022
Q3 		$42K Buy
+2,055
New +$45.1K ﹤0.01% 1862

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's ANGO Position: Q2 2023 in Review

Steward Partners Investment Advisory sold out of AngioDynamics (ANGO) in Q2 2023, closing a stake of 1,344 shares — an estimated $13.9K sold.

Steward Partners Investment Advisory first reported a position in ANGO in Q3 2022 and held it in 3 quarters. The position peaked at $42K in Q3 2022. 156 funds tracked by Wall St. Rank hold ANGO as of Q2 2023.

  • Steward Partners Investment Advisory reported no remaining AngioDynamics position as of Q2 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,344 AngioDynamics shares in Q2 2023, an estimated $13.9K.
  • Steward Partners Investment Advisory first reported a position in AngioDynamics in Q3 2022 and held it in 3 quarters.
  • Steward Partners Investment Advisory's AngioDynamics position peaked at $42K in Q3 2022.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2023, filed 14 Aug 2023.